178 related articles for article (PubMed ID: 28939130)
41. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
Miotto D; Lo Cascio N; Stendardo M; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
Lung Cancer; 2010 Sep; 69(3):355-60. PubMed ID: 20089329
[TBL] [Abstract][Full Text] [Related]
42. The distribution and function of human memory T cell subsets in lung cancer.
Sheng SY; Gu Y; Lu CG; Zou JY; Hong H; Wang R
Immunol Res; 2017 Jun; 65(3):639-650. PubMed ID: 28101811
[TBL] [Abstract][Full Text] [Related]
43. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T
Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295
[TBL] [Abstract][Full Text] [Related]
44. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
[TBL] [Abstract][Full Text] [Related]
45. Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients.
Prado-Garcia H; Aguilar-Cazares D; Flores-Vergara H; Mandoki JJ; Lopez-Gonzalez JS
Lung Cancer; 2005 Mar; 47(3):361-71. PubMed ID: 15713519
[TBL] [Abstract][Full Text] [Related]
46. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
47. Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer.
Jiang L; Zhao Z; Jiang S; Lin Y; Yang H; Xie Z; Lin Y; Long H
Immunol Res; 2015 Jul; 62(3):316-24. PubMed ID: 25999209
[TBL] [Abstract][Full Text] [Related]
48. Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non-Small Cell Lung Cancer.
Tassi E; Grazia G; Vegetti C; Bersani I; Bertolini G; Molla A; Baldassari P; Andriani F; Roz L; Sozzi G; Pastorino U; Mortarini R; Anichini A
Cancer Res; 2017 Feb; 77(4):851-861. PubMed ID: 27979840
[TBL] [Abstract][Full Text] [Related]
49. Immune Response After Radiofrequency Ablation and Surgical Resection in Nonsmall Cell Lung Cancer.
Schneider T; Hoffmann H; Dienemann H; Herpel E; Heussel CP; Enk AH; Ring S; Mahnke K
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):585-592. PubMed ID: 28043482
[TBL] [Abstract][Full Text] [Related]
50. CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.
Hald SM; Bremnes RM; Al-Shibli K; Al-Saad S; Andersen S; Stenvold H; Busund LT; Donnem T
Lung Cancer; 2013 May; 80(2):209-15. PubMed ID: 23384671
[TBL] [Abstract][Full Text] [Related]
51. Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.
Yi JS; Ready N; Healy P; Dumbauld C; Osborne R; Berry M; Shoemaker D; Clarke J; Crawford J; Tong B; Harpole D; D'Amico TA; McSherry F; Dunphy F; McCall SJ; Christensen JD; Wang X; Weinhold KJ
Clin Cancer Res; 2017 Dec; 23(24):7474-7482. PubMed ID: 28951518
[No Abstract] [Full Text] [Related]
52. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
53. Preoperative peripheral naïve / memory ratio and prognosis of nonsmall-cell lung cancer patients.
Hara M; Matsuzaki Y; Shimizu T; Tomita M; Ayabe T; Enomoto Y; Onitsuka T
Ann Thorac Cardiovasc Surg; 2007 Dec; 13(6):384-90. PubMed ID: 18292720
[TBL] [Abstract][Full Text] [Related]
54. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
[TBL] [Abstract][Full Text] [Related]
55. Altered frequency of CD8
Rostamzadeh D; Haghshenas MR; Daryanoosh F; Samadi M; Hosseini A; Ghaderi A; Mojtahedi Z; Babaloo Z
J Cell Physiol; 2019 Jul; 234(7):11986-11998. PubMed ID: 30623416
[TBL] [Abstract][Full Text] [Related]
56. [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].
Ji P; Chen D; Bian J; Xia R; Song X; Wen W; Zhang X; Zhu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):808-11. PubMed ID: 26062425
[TBL] [Abstract][Full Text] [Related]
57. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
58. Identifying predictive biomarkers of CIMAvaxEGF success in non-small cell lung cancer patients.
Lorenzo-Luaces P; Sanchez L; Saavedra D; Crombet T; Van der Elst W; Alonso A; Molenberghs G; Lage A
BMC Cancer; 2020 Aug; 20(1):772. PubMed ID: 32807114
[TBL] [Abstract][Full Text] [Related]
59. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
60. In situ activation of helper T cells in the lung.
Raju B; Tung CF; Cheng D; Yousefzadeh N; Condos R; Rom WN; Tse DB
Infect Immun; 2001 Aug; 69(8):4790-8. PubMed ID: 11447152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
